Checkpoint Inhibitors for the Treatment of Renal Cell Carcinoma.
about
Novel immunotherapy in metastatic renal cell carcinoma.Combined mutation in Vhl, Trp53 and Rb1 causes clear cell renal cell carcinoma in mice.Cell death-based approaches in treatment of the urinary tract-associated diseases: a fight for survival in the killing fields.The efficacy and safety of anti-PD-1/PD-L1 antibody therapy versus docetaxel for pretreated advanced NSCLC: a meta-analysis.The Correlation Between the Immune and Epithelial-Mesenchymal Transition Signatures Suggests Potential Therapeutic Targets and Prognosis Prediction Approaches in Kidney Cancer.The Identification of Immunological Biomarkers in Kidney Cancers
P2860
Checkpoint Inhibitors for the Treatment of Renal Cell Carcinoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Checkpoint Inhibitors for the Treatment of Renal Cell Carcinoma.
@en
type
label
Checkpoint Inhibitors for the Treatment of Renal Cell Carcinoma.
@en
prefLabel
Checkpoint Inhibitors for the Treatment of Renal Cell Carcinoma.
@en
P2093
P2860
P1476
Checkpoint Inhibitors for the Treatment of Renal Cell Carcinoma.
@en
P2093
Daniel M Geynisman
Elizabeth R Plimack
Matthew Zibelman
Pooja Ghatalia
P2860
P2888
P356
10.1007/S11864-017-0458-0
P577
2017-01-01T00:00:00Z
P6179
1083845789